220 related articles for article (PubMed ID: 24680796)
1. Randomized controlled trial of sildenafil for preventing recurrent ischemic priapism in sickle cell disease.
Burnett AL; Anele UA; Trueheart IN; Strouse JJ; Casella JF
Am J Med; 2014 Jul; 127(7):664-8. PubMed ID: 24680796
[TBL] [Abstract][Full Text] [Related]
2. Prevention of Ischemic Priapism in Sickle Cell Disease: Sildenafil: Commentary on: Randomized Controlled Trial of Sildenafil for Preventing Recurrent Ischemic Priapism in Sickle Cell Disease.
Shakeri A; Van Asseldonk B; Elterman DS
Urology; 2015 Dec; 86(6):1055-6. PubMed ID: 26431892
[No Abstract] [Full Text] [Related]
3. Potential risks of chronic sildenafil use for priapism in sickle cell disease.
Lane A; Deveras R
J Sex Med; 2011 Nov; 8(11):3193-5. PubMed ID: 21883942
[TBL] [Abstract][Full Text] [Related]
4. Sildenafil promotes eNOS activation and inhibits NADPH oxidase in the transgenic sickle cell mouse penis.
Musicki B; Bivalacqua TJ; Champion HC; Burnett AL
J Sex Med; 2014 Feb; 11(2):424-30. PubMed ID: 24251665
[TBL] [Abstract][Full Text] [Related]
5. Sildenafil citrate-restored eNOS and PDE5 regulation in sickle cell mouse penis prevents priapism via control of oxidative/nitrosative stress.
Bivalacqua TJ; Musicki B; Hsu LL; Berkowitz DE; Champion HC; Burnett AL
PLoS One; 2013; 8(7):e68028. PubMed ID: 23844149
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of sildenafil citrate in the treatment of erectile dysfunction in patients with ischemic heart disease.
Conti CR; Pepine CJ; Sweeney M
Am J Cardiol; 1999 Mar; 83(5A):29C-34C. PubMed ID: 10078540
[TBL] [Abstract][Full Text] [Related]
7. Long-term oral phosphodiesterase 5 inhibitor therapy alleviates recurrent priapism.
Burnett AL; Bivalacqua TJ; Champion HC; Musicki B
Urology; 2006 May; 67(5):1043-8. PubMed ID: 16698365
[TBL] [Abstract][Full Text] [Related]
8. Regimented Phosphodiesterase Type 5 Inhibitor Use Reduces Emergency Department Visits for Recurrent Ischemic Priapism.
Hou LT; Burnett AL
J Urol; 2021 Feb; 205(2):545-553. PubMed ID: 32915079
[TBL] [Abstract][Full Text] [Related]
9. Understanding the effects of sildenafil treatment on erection maintenance and erection hardness.
Claes HIM; Goldstein I; Althof SE; Berner MM; Cappelleri JC; Bushmakin AG; Symonds T; Schnetzler G
J Sex Med; 2010 Jun; 7(6):2184-2191. PubMed ID: 20384942
[TBL] [Abstract][Full Text] [Related]
10. Sickle cell disease status and outcomes of African-American men presenting with priapism.
Bennett N; Mulhall J
J Sex Med; 2008 May; 5(5):1244-1250. PubMed ID: 18312286
[TBL] [Abstract][Full Text] [Related]
11. Priapism in an infant with sickle cell trait after cardiac transplant.
Bacsu CD; Metcalfe PD
Urology; 2012 Oct; 80(4):928-30. PubMed ID: 22901818
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic sildenafil citrate improves select aspects of sexual function in men treated with radiotherapy for prostate cancer.
Zelefsky MJ; Shasha D; Branco RD; Kollmeier M; Baser RE; Pei X; Ennis R; Stock R; Bar-Chama N; Mulhall JP
J Urol; 2014 Sep; 192(3):868-74. PubMed ID: 24603102
[TBL] [Abstract][Full Text] [Related]
13. Prevention of recurrent ischemic priapism with ketoconazole: evolution of a treatment protocol and patient outcomes.
Hoeh MP; Levine LA
J Sex Med; 2014 Jan; 11(1):197-204. PubMed ID: 24433561
[TBL] [Abstract][Full Text] [Related]
14. Men with mild erectile dysfunction benefit from sildenafil treatment.
Bénard F; Carrier S; Lee JC; Talwar V; Defoy I
J Sex Med; 2010 Nov; 7(11):3725-35. PubMed ID: 20946161
[TBL] [Abstract][Full Text] [Related]
15. Unsatisfactory outcomes of prolonged ischemic priapism without early surgical shunts: our clinical experience and a review of the literature.
Zheng DC; Yao HJ; Zhang K; Xu MX; Chen Q; Chen YB; Cai ZK; Lu MJ; Wang Z
Asian J Androl; 2013 Jan; 15(1):75-8. PubMed ID: 22922321
[TBL] [Abstract][Full Text] [Related]
16. Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial.
Redfield MM; Chen HH; Borlaug BA; Semigran MJ; Lee KL; Lewis G; LeWinter MM; Rouleau JL; Bull DA; Mann DL; Deswal A; Stevenson LW; Givertz MM; Ofili EO; O'Connor CM; Felker GM; Goldsmith SR; Bart BA; McNulty SE; Ibarra JC; Lin G; Oh JK; Patel MR; Kim RJ; Tracy RP; Velazquez EJ; Anstrom KJ; Hernandez AF; Mascette AM; Braunwald E;
JAMA; 2013 Mar; 309(12):1268-77. PubMed ID: 23478662
[TBL] [Abstract][Full Text] [Related]
17. Effect of testosterone replacement on response to sildenafil citrate in men with erectile dysfunction: a parallel, randomized trial.
Spitzer M; Basaria S; Travison TG; Davda MN; Paley A; Cohen B; Mazer NA; Knapp PE; Hanka S; Lakshman KM; Ulloor J; Zhang A; Orwoll K; Eder R; Collins L; Mohammed N; Rosen RC; DeRogatis L; Bhasin S
Ann Intern Med; 2012 Nov; 157(10):681-91. PubMed ID: 23165659
[TBL] [Abstract][Full Text] [Related]
18. Subacute Hemolysis in Sickle Cell Mice Causes Priapism Secondary to NO Imbalance and PDE5 Dysregulation.
Sopko NA; Matsui H; Hannan JL; Berkowitz D; Champion HC; Hsu LL; Musicki B; Burnett AL; Bivalacqua TJ
J Sex Med; 2015 Sep; 12(9):1878-85. PubMed ID: 26346631
[TBL] [Abstract][Full Text] [Related]
19. Sildenafil citrate for erectile dysfunction in patients with multiple sclerosis.
Xiao Y; Wang J; Luo H
Cochrane Database Syst Rev; 2012 Apr; (4):CD009427. PubMed ID: 22513975
[TBL] [Abstract][Full Text] [Related]
20. Effect of sildenafil citrate on the male sexual experience assessed with the Sexual Experience Questionnaire: a multicenter, double-blind, placebo-controlled trial with open-label extension.
Jones LA; Klimberg IW; McMurray JG; Padula R; Tseng LJ; Stecher VJ
J Sex Med; 2008 Aug; 5(8):1955-64. PubMed ID: 18564150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
